Skip to content

Clinical Effect and Mechanism of co-treatment with acupuncture plus Chinese herbal medicine for premature ovarian insufficiency (POI)

Clinical Effect and Mechanism of co-treatment with acupuncture plus Chinese herbal medicine for premature ovarian insufficiency (POI)

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039796
Enrollment
Unknown
Registered
2020-11-10
Start date
2020-11-15
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature ovarian insufficiency (POI)

Interventions

Sponsors

Tongxiang Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Between 18 and 40 years of age; 2. Those who meet the diagnostic criteria of TCM and Western medicine; 3. Urine pregnancy test negative; 4. Those who did not receive any relevant treatment within 3 months prior to the start of the study; 5. Patients with informed consent and voluntary participation, can cooperate with the completion of clinical researchers.

Exclusion criteria

Exclusion criteria: 1. Female reproductive system anatomical abnormalities; 2. In the past three months, the use of hormones, traditional Chinese medicine or acupuncture treatment; 3. Complicated with other gynecological reproductive endocrine diseases, such as endometriosis, hyper prolactinemia, polycystic ovary syndrome, gonadal dysplasia; 4. History of autoimmune diseases; 5. Patients with severe primary diseases, such as cardiovascular and cerebrovascular diseases, liver, kidney and hematopoietic system; Those who participated in other clinical trials at the same time did; 6. Not end or took other drugs that affected the study; 7. There are contraindications of acupuncture, such as large area of skin infection, rupture and so on;?? 8. Not according to the prescribed medication, can not judge the efficacy, or incomplete data and other effects on the efficacy of the judge.

Design outcomes

Primary

MeasureTime frame
The TCM clinical symptom scores;

Secondary

MeasureTime frame
Kupperman Index;Reproductive endocrine hormone levels ;Ultrasound imaging indicators ;

Countries

China

Contacts

Public ContactLi huifang

Tongxiang Maternal and Child Health Hospital

747010316@qq.com+86 18857381345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026